These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 20013887)

  • 1. Resveratrol bioavailability and toxicity in humans.
    Cottart CH; Nivet-Antoine V; Laguillier-Morizot C; Beaudeux JL
    Mol Nutr Food Res; 2010 Jan; 54(1):7-16. PubMed ID: 20013887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and bioavailability of trans-resveratrol.
    Wenzel E; Somoza V
    Mol Nutr Food Res; 2005 May; 49(5):472-81. PubMed ID: 15779070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of resveratrol: What formulation solutions to bioavailability limitations?
    Amri A; Chaumeil JC; Sfar S; Charrueau C
    J Control Release; 2012 Mar; 158(2):182-93. PubMed ID: 21978644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of resveratrol.
    Walle T
    Ann N Y Acad Sci; 2011 Jan; 1215():9-15. PubMed ID: 21261636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of resveratrol bioavailability in the perfused small intestine of the rat.
    Andlauer W; Kolb J; Siebert K; Fürst P
    Drugs Exp Clin Res; 2000; 26(2):47-55. PubMed ID: 10894555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells.
    Panaro MA; Carofiglio V; Acquafredda A; Cavallo P; Cianciulli A
    Br J Nutr; 2012 Nov; 108(9):1623-32. PubMed ID: 22251620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.
    Cottart CH; Nivet-Antoine V; Beaudeux JL
    Mol Nutr Food Res; 2014 Jan; 58(1):7-21. PubMed ID: 23740855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.
    de la Lastra CA; Villegas I
    Mol Nutr Food Res; 2005 May; 49(5):405-30. PubMed ID: 15832402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.
    Shu XH; Li H; Sun Z; Wu ML; Ma JX; Wang JM; Wang Q; Sun Y; Fu YS; Chen XY; Kong QY; Liu J
    Biochem Pharmacol; 2010 May; 79(10):1516-25. PubMed ID: 20105429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice.
    Meng X; Maliakal P; Lu H; Lee MJ; Yang CS
    J Agric Food Chem; 2004 Feb; 52(4):935-42. PubMed ID: 14969553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol and liver disease: from bench to bedside and community.
    Bishayee A; Darvesh AS; Politis T; McGory R
    Liver Int; 2010 Sep; 30(8):1103-14. PubMed ID: 20557453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol and health--a comprehensive review of human clinical trials.
    Smoliga JM; Baur JA; Hausenblas HA
    Mol Nutr Food Res; 2011 Aug; 55(8):1129-41. PubMed ID: 21688389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of trans-resveratrol from red wine in humans.
    Vitaglione P; Sforza S; Galaverna G; Ghidini C; Caporaso N; Vescovi PP; Fogliano V; Marchelli R
    Mol Nutr Food Res; 2005 May; 49(5):495-504. PubMed ID: 15830336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and pharmacokinetics of resveratrol and pterostilbene.
    Wang P; Sang S
    Biofactors; 2018 Jan; 44(1):16-25. PubMed ID: 29315886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.
    Gambini J; Inglés M; Olaso G; Lopez-Grueso R; Bonet-Costa V; Gimeno-Mallench L; Mas-Bargues C; Abdelaziz KM; Gomez-Cabrera MC; Vina J; Borras C
    Oxid Med Cell Longev; 2015; 2015():837042. PubMed ID: 26221416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Synthesis, Bioactivity, and Pharmacokinetics of Pterostilbene, an Important Analog of Resveratrol.
    Liu Y; You Y; Lu J; Chen X; Yang Z
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High absorption but very low bioavailability of oral resveratrol in humans.
    Walle T; Hsieh F; DeLegge MH; Oatis JE; Walle UK
    Drug Metab Dispos; 2004 Dec; 32(12):1377-82. PubMed ID: 15333514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance'.
    Lindsay DG
    Hum Exp Toxicol; 2010 Dec; 29(12):1024-5. PubMed ID: 21115563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol: review on therapeutic potential and recent advances in drug delivery.
    Pangeni R; Sahni JK; Ali J; Sharma S; Baboota S
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1285-98. PubMed ID: 24830814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.
    Rotches-Ribalta M; Urpi-Sarda M; Llorach R; Boto-Ordoñez M; Jauregui O; Chiva-Blanch G; Perez-Garcia L; Jaeger W; Guillen M; Corella D; Tinahones FJ; Estruch R; Andres-Lacueva C
    J Chromatogr A; 2012 Nov; 1265():105-13. PubMed ID: 23089514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.